Strategy
Our objective is to be a leading developer of innovative products that provide safer and more effective diagnosis and treatment of AF. Our primary goal is to commercialize all of our REVELATION(R) series of ablation products for the treatment of AF in the electrophysiology market.
Our Surgical Ablation System (SAS), a micro-catheter-based surgical probe coupled to the INTELLITEMP(R), a RF energy management device, received 510(k) clearance for use in the United States in January 2003. Due to our focus on the EP market, we do not currently plan to market our SAS ourselves, and are currently seeking to sell or otherwise...
read more
QUOTE
As of 08:55AM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
CRDM |
| SIC: |
-
|
| State location: |
CA |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
28 |
| Type: |
NASDAQ |
CARDIMA, INC (CRDM) MESSAGE BOARD
| Post # |
Subject |
Re |
Name |
Date |
| There are no comments. |
someone replies to your post?